Ernexa Therapeutics Inc. Total Contract Liability
Ernexa Therapeutics Inc. (ERNA) had Total Contract Liability of $0 as of 2024-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-03-13
- 2024-12-31: Contract with Customer, Liability $0.00.
- 2023-12-31: Contract with Customer, Liability $100.00K.
- 2022-12-31: Contract with Customer, Liability $0.00.
- 2020-12-31: Contract with Customer, Liability $78.00K.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-13 | |
| 2023-12-31 | $100.00K 10-K · filed 2024-03-14 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 | |
| 2020-12-31 | $78.00K 10-K · filed 2021-03-11 | |
| 2020-09-30 | $120.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $378.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $384.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $460.00K 10-K · filed 2021-03-11 | $462.00K 10-K · filed 2020-03-19 |
| 2019-09-30 | $756.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $535.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.22M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.30M 10-K · filed 2020-03-19 | $1.40M 10-K · filed 2019-03-22 |
| 2017-12-31 | $3.63M 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |